Polypoidal choroidal vasculopathy with multiple polyps has poorer response to ranibizumab

Polypoidal choroidal vasculopathy with multiple polyps did not respond as well to intravitreal ranibizumab as polypoidal choroidal vasculopathy with a single polyp, according to a study conducted in Japan.“We propose that the stratification of PCV lesions by polyp number may be valuable to understand the prognosis of this condition,” the study authors said.